POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis
Completed · Phase 2
Conditions studied: Atopic Dermatitis
In brief
The study is a multicenter clinical trial and is designed as a proof-of-concept study to evaluate the efficacy, safety, tolerability, PK, immunogenicity, and PD of BSI-045B following SC injections. The study will enroll patients with moderate to severe AD to receive the 300 mg treatment. BSI-045B wil be firstly given weekly during Week 1 to Week 4, and then every 2 weeks (Q2W) to Week 24.
Key facts
- Study ID
- NCT05932654
- Run by
- Biosion, Inc.
- People needed
- 22
- Starts
- 2023-07-31
- Expected to finish
- 2024-09-18
- Last updated by the study team
- 2025-10-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- First OC Dermatology - Fountain Valley — Fountain Valley, California, United States
- Center for Dermatology Clinical Research — Fremont, California, United States
- Profound Research LLC - Nashville - Corporate — Oceanside, California, United States
- The George Washington University School of Medicine and Health Science — Washington D.C., District of Columbia, United States
- Advanced Medical Research - Medical Dermatology Specialists — Sandy Springs, Georgia, United States
- Dawes Fretzin Clinical Research — Indianapolis, Indiana, United States
- Skin Sciences/Derm Research Pllc. — Louisville, Kentucky, United States
- Allcutis Research - Beverly, MA — Beverly, Massachusetts, United States
- Beacon Clinical Research — Quincy, Massachusetts, United States
- Sadick Research Group — New York, New York, United States
- Accellacare - Cary — Cary, North Carolina, United States
- Accellacare - Raleigh — Raleigh, North Carolina, United States
- Accellacare-Wilmington — Wilmington, North Carolina, United States
- Wright State Physicians Health Center — Fairborn, Ohio, United States
- Paddington Testing Company — Philadelphia, Pennsylvania, United States
- Center for Clinical Studies - Webster — Webster, Texas, United States
- Dermatology Specialists of Spokane — Spokane, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.